DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Ornstein MC, Pal SK, Wood LS. et al.
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol 2019;
20 (10) 1386-1394
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.